142 related articles for article (PubMed ID: 34030794)
1. EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Ishioh M; Takakusaki K; Okumura T
J Pharmacol Sci; 2021 Jul; 146(3):121-124. PubMed ID: 34030794
[TBL] [Abstract][Full Text] [Related]
2. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
[TBL] [Abstract][Full Text] [Related]
3. Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
Neurogastroenterol Motil; 2020 Jun; 32(6):e13819. PubMed ID: 32056324
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
Eur J Pharmacol; 2019 Jun; 852():198-206. PubMed ID: 30935894
[TBL] [Abstract][Full Text] [Related]
5. Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Biomed Pharmacother; 2021 Jul; 139():111649. PubMed ID: 33957565
[TBL] [Abstract][Full Text] [Related]
6. Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models.
Nozu T; Arie H; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Int Immunopharmacol; 2024 May; 133():112099. PubMed ID: 38643709
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
J Pharmacol Sci; 2019 Jan; 139(1):46-49. PubMed ID: 30522964
[TBL] [Abstract][Full Text] [Related]
8. Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
Sci Rep; 2019 Dec; 9(1):19603. PubMed ID: 31862976
[TBL] [Abstract][Full Text] [Related]
9. Peripheral apelin mediates visceral hypersensitivity and impaired gut barrier in a rat irritable bowel syndrome model.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Neuropeptides; 2022 Aug; 94():102248. PubMed ID: 35526468
[TBL] [Abstract][Full Text] [Related]
10. Imeglimin prevents visceral hypersensitivity and colonic hyperpermeability in irritable bowel syndrome rat model.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
J Pharmacol Sci; 2023 Sep; 153(1):26-30. PubMed ID: 37524451
[TBL] [Abstract][Full Text] [Related]
11. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
J Endocrinol; 2018 Nov; 239(2):241-252. PubMed ID: 30139928
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats.
Nozu T; Miyagishi S; Kumei S; Nozu R; Takakusaki K; Okumura T
J Gastroenterol Hepatol; 2019 Jan; 34(1):186-193. PubMed ID: 29966173
[TBL] [Abstract][Full Text] [Related]
13. Visceral hypersensitivity in irritable bowel syndrome.
Kanazawa M; Hongo M; Fukudo S
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies.
Anand U; Yiangou Y; Sinisi M; Fox M; MacQuillan A; Quick T; Korchev YE; Bountra C; McCarthy T; Anand P
Mol Pain; 2015 Jun; 11():38. PubMed ID: 26111701
[TBL] [Abstract][Full Text] [Related]
15. The comprehensive pathophysiological changes in a novel rat model of postinflammatory visceral hypersensitivity.
Ma J; Li J; Qian M; He N; Cao Y; Liu Y; Wu K; He S
FASEB J; 2019 Dec; 33(12):13560-13571. PubMed ID: 31570003
[TBL] [Abstract][Full Text] [Related]
16. Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats.
Nozu T; Miyagishi S; Kumei S; Nozu R; Takakusaki K; Okumura T
Eur J Pharmacol; 2018 Jan; 818():228-234. PubMed ID: 29107672
[TBL] [Abstract][Full Text] [Related]
17. Multispecies probiotic protects gut barrier function in experimental models.
Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V
World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons.
Anand U; Facer P; Yiangou Y; Sinisi M; Fox M; McCarthy T; Bountra C; Korchev YE; Anand P
Eur J Pain; 2013 Aug; 17(7):1012-26. PubMed ID: 23255326
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive Effect of Ghrelin in a Rat Model of Irritable Bowel Syndrome Involves TRPV1/Opioid Systems.
Mao Y; Li Z; Chen K; Yu H; Zhang S; Jiang M; Ma Y; Liang C; Liu H; Li H; Hua Q; Zhou H; Sun Y; Fan X
Cell Physiol Biochem; 2017; 43(2):518-530. PubMed ID: 28930716
[TBL] [Abstract][Full Text] [Related]
20. Grape Seed Extract Eliminates Visceral Allodynia and Colonic Hyperpermeability Induced by Repeated Water Avoidance Stress in Rats.
Arie H; Nozu T; Miyagishi S; Ida M; Izumo T; Shibata H
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
